Medicine and Dentistry
Antiplatelet
100%
Mesenteric Ischemia
100%
Systematic Review
100%
Symptom
100%
Combination Therapy
83%
Mortality Rate
50%
Therapeutic Procedure
50%
Recurrent Disease
33%
Assessment
33%
Meta-Analysis
33%
Follow up
33%
Inpatient
33%
Randomized Controlled Trial
16%
Patient
16%
Retrospective Study
16%
Female
16%
Superior Mesenteric Artery
16%
Observational Study
16%
Age
16%
Surgical Mortality
16%
Mortality
16%
Prevalence
16%
Meta-Regression
16%
Regression Analysis
16%
Disease Exacerbation
16%
Nursing and Health Professions
Symptom
100%
Mesenteric Ischemia
100%
Dual Antiplatelet Therapy
50%
Mortality Rate
50%
Combination Therapy
33%
Follow up
33%
Meta Analysis
33%
Recurrent Disease
33%
Prevention
16%
Cochrane Library
16%
Mortality
16%
Medline
16%
Quality Control
16%
Regression Analysis
16%
Surgical Mortality
16%
Perioperative
16%
Embase
16%
Practice Guideline
16%
Prevalence
16%
Disease Exacerbation
16%
Pharmacology, Toxicology and Pharmaceutical Science
Anticoagulant Agent
100%
Symptom
100%
Mesenteric Ischemia
100%
Mortality Rate
50%
Recurrent Disease
33%
Disease Exacerbation
16%
Prevalence
16%
Surgical Mortality
16%
Mortality
16%